Arphra/Issuer/LALPATHLAB.NS

LALPATHLAB.NS

Dr. Lal PathLabs Limited

HealthcareMedical - Diagnostics & ResearchININRCountry macro →

$1,561.00

Jun 02, 2026

AI Brief

Revenue · FY

$27.63B

Net income

$5.05B

FY 2026

EPS · diluted

$30.20

EBITDA

$7.83B

Explain this page

Arphra AIPlain-English read on Dr. Lal PathLabs Limited’s valuation

AI Issuer Brief

Arphra AI

Loading cached brief…

Insider · 30d

Bought

0 txns

Sold

0 txns

Net flow

+$0

Full history →

Price

DB · prices_daily

1M 6M 1Y 5Y

Last

$1561.00

Change

+9.20%

Period high

$1703.70

Period low

$1307.60

Period start

$1429.502026-02-01

Through 2026-06-02

Peers

No peer list available for LALPATHLAB.NS.

Sector & industry today

Live

Sectors

Healthcare
+1.32%
Financial Services
+1.14%
Industrials
+0.68%
Consumer Cyclical
+0.59%
Energy
+0.52%
Real Estate
+0.46%
Consumer Defensive
+0.12%
Basic Materials
-0.28%
Utilities
-1.42%
Communication Services
-1.84%
Technology
-2.36%

Top industries (issuer's industry highlighted)

No industry data returned.

Fair value

Football field →

Weighted blend

$661.38

— vs spot

Recommendation

n/a

3 of 3 methods

Method spread

0bull0bear

±5% threshold

Total assets

$31.46B

Total debt

$1.99B

Cash & equiv

$9.1B

Operating CF

$7.02B

Free cash flow

$5.35B

Buybacks

Analyst view

Consensus target

—

No price-target data returned for this ticker.

Recent actions

0 ↑0 ↓0 hold

No recent grade actions.

News

DB · news_items

No recent news for LALPATHLAB.NS.

Recent quarters

All financials →

Period	Revenue	Net income	EPS

Recent insiders

All →

Insider	Action	Shares	Value	Date
No open-market insider activity in the recent window.

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin
FY 2026	$27.63B	$6.21B	$5.05B	$30.20	+18.27%